rs2850878
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001480.4(GALR1):c.732+1483G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.787 in 152,144 control chromosomes in the GnomAD database, including 47,184 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.79 ( 47184 hom., cov: 33)
Consequence
GALR1
NM_001480.4 intron
NM_001480.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.280
Publications
1 publications found
Genes affected
GALR1 (HGNC:4132): (galanin receptor 1) The neuropeptide galanin elicits a range of biological effects by interaction with specific G-protein-coupled receptors. Galanin receptors are seven-transmembrane proteins shown to activate a variety of intracellular second-messenger pathways. GALR1 inhibits adenylyl cyclase via a G protein of the Gi/Go family. GALR1 is widely expressed in the brain and spinal cord, as well as in peripheral sites such as the small intestine and heart. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.804 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.787 AC: 119607AN: 152026Hom.: 47150 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
119607
AN:
152026
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.787 AC: 119694AN: 152144Hom.: 47184 Cov.: 33 AF XY: 0.787 AC XY: 58503AN XY: 74374 show subpopulations
GnomAD4 genome
AF:
AC:
119694
AN:
152144
Hom.:
Cov.:
33
AF XY:
AC XY:
58503
AN XY:
74374
show subpopulations
African (AFR)
AF:
AC:
33390
AN:
41520
American (AMR)
AF:
AC:
12473
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
3053
AN:
3472
East Asian (EAS)
AF:
AC:
3405
AN:
5168
South Asian (SAS)
AF:
AC:
3404
AN:
4824
European-Finnish (FIN)
AF:
AC:
8122
AN:
10576
Middle Eastern (MID)
AF:
AC:
233
AN:
294
European-Non Finnish (NFE)
AF:
AC:
53185
AN:
67976
Other (OTH)
AF:
AC:
1666
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1332
2664
3997
5329
6661
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
872
1744
2616
3488
4360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2372
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.